3WHO. International drug monitoring: the role of national centres. Tech Rep Ser WHO 1972, no498. 被引量：1
4Laurence D, Carpenter J. A dictionary of pharmacology and allied topics, 2nd edn. Amsterdam: Elsevier, 1998: 8-9. 被引量：1
5Stephens MDB. Definitions and classifications of adverse reaction terms. In: Stephens MDB, Talbot JCC, Routledge PA, eds. The detection of new adverse reactions, 4th edn. London: Macmillan Reference, 1998: 32 - 44. 被引量：1
6Ferner RE, Aronson JK. Errors in prescribing,preparing, and giving medicines- definition, classification, and prevention. In: Aronson JK, ed.Side effects of drugs, annual 22. A worldwide yearly survey of new data and trends. Amsterdam:Elsevier, 1999: xxiii - xxxvi. 被引量：1
7Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29 - 34. 被引量：1
8Council for International Organizations of Medical Sciences. Basic requirements for the use of terms for reporting adverse drug reactions. Pharmacoepidemiol Drug Saf 1992; 1: 39 - 45. 被引量：1
9WHO. International monitoring of adverse reactions to drugs: adverse reaction terminology.WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden, 1992. 被引量：1
10Wood KL, on behalf of the MEDDRA Working Party. The medical dictionary for drug regulatory affairs (MEDDRA). Pharmacoepidemiol Drug Saf1994; 3: 7- 13. 被引量：1
